AXTA vs NGD

AXTA's deterministic scorecard shows a Piotroski F-Score of 4/9, indicating stable but not strong financial health, and the absence of an Altman Z-Score prevents a full distress risk assessment. The stock trades below the growth-based intrinsic value of $48.10 but above the conservative Graham Number of $22.25, suggesting mixed valuation signals. Despite solid profitability metrics like a 21.33% ROE and consistent earnings beats, revenue is contracting YoY by 2.40%, and insider activity is bearish with recent selling. Analysts recommend a 'buy' with a $36.71 target, implying moderate upside from current levels around $33.62.

NGD presents a high-growth profile with a stable Piotroski F-Score of 4/9 and a current price ($9.08) trading very close to its growth-based intrinsic value ($9.44). While the Graham Number ($3.36) suggests a defensive undervaluation gap, the stock's massive earnings growth (275% YoY) and a highly attractive Forward P/E of 7.69 justify the current premium. Despite strong profitability and low debt/equity, short-term liquidity is a concern with a current ratio of 0.88. The overall outlook is bullish based on fundamental expansion, though technicals remain bearish in the short term.